Polio-New challenges in 2006

Journal of Clinical Virology

Volumn 36, Issue 3, 2006, Pages 163-165

  Katz, Samuel L ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eradication; Polio; Problems; Vaccines

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

AFRICA; CIRCULATING VACCINE DERIVED POLIOVIRUS; EPIDEMIC; HEALTH PROGRAM; HUMAN; IMMUNE DEFICIENCY; INDONESIA; INFECTION CONTROL; MEDICAL RESEARCH; MIDDLE EAST; NIGERIA; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

AFRICA, CENTRAL; HUMANS; IMMUNIZATION PROGRAMS; INDONESIA; MIDDLE EAST; NIGERIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 33744983894     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.03.003     Document Type: Review

References (15)

1. Aylward R.B., Sutter R.W., and Heymann D.L. OPV cessation-the final step to a "polio-free" world. Science 310 (2005) 625-626
2. Caceres V.M., and Sutter R.W. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 33 (2001) 533-541
3. CDC. Poliomyelitis prevention in the United States; updated recommendations of the Advisory Committee on Immunization Practices {ACIP}. MMWR 49 (2000) [No. RR-5]
4. CDC. Progress toward interruption of wild poliovirus transmission. MMWR 54 (2005) 408-412
5. CDC. Poliovirus infections in four unvaccinated children-Minnesota. MMWR 54 (2005) 1053-1055
6. CDC. Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 countries, 2002-2005. MMWR 55 (2006) 145-150
7. Dowdle W.R., Wolff C., Sanders R., Lambert S., and Best M. Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?. Bull WHO 82 (2004) 59-62
8. Fenner F., Henderson D.A., Artia I., Jezek Z., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneva
9. Hopkins D.R. Princes and peasants, smallpox in history (1983), University of Chicago Press 380 pp
10. Huang Q.S., Greening G., Barker M.G., Grimwood K., Hewitt J., Hulston D., et al. Persistence of oral polio vaccine virus after its removal from the immunization schedule in New Zealand. Lancet 366 (2005) 394-396
11. Hull H.F., and Minor P.D. When can we stop using oral poliovirus vaccine?. J Infect Dis 192 (2005) 2033-2035
12. Kew O.M., Sutter R.W., deGourville E.M., Dowdle W.R., and Pallansch M.A. Vaccines-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
13. MacLennan C., Dunn G., Huisson A.P., Knmararatne D.S., Martin J., O'Leary P., et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363 (2004) 1509-1513
14. National Research Council. Exploring the role of antiviral drugs in the eradication of polio. Workshop report. National Academy of Sciences. in press.
15. World Health Assembly. Global eradication of poliomyelitis by the year 2000. Resolution 41-28 of the 41st World Health Assembly (1988), World Health Organization, Geneva, Switzerland